Raphael Pharmaceutical Financials

RAPH Stock   0.26  0.00  0.00%   
Raphael Pharmaceutical is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.
With this module, you can analyze Raphael financials for your investing period. You should be able to track the changes in Raphael Pharmaceutical individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
The data published in Raphael Pharmaceutical's official financial statements typically reflect Raphael Pharmaceutical's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Raphael Pharmaceutical's quantitative information. For example, before you start analyzing numbers published by Raphael accountants, it's essential to understand Raphael Pharmaceutical's liquidity, profitability, and earnings quality within the context of the Raphael space in which it operates.
InstrumentUSA OTC Stock View All
ExchangeOTCQB Exchange
BenchmarkDow Jones Industrial

Raphael Pharmaceutical Key Financial Ratios

Raphael Pharmaceutical's financial ratios allow both analysts and investors to convert raw data from Raphael Pharmaceutical's financial statements into concise, actionable information that can be used to evaluate the performance of Raphael Pharmaceutical over time and compare it to other companies across industries.

Raphael Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Raphael Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Raphael Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Raphael Pharmaceutical competition to find correlations between indicators driving Raphael Pharmaceutical's intrinsic value. More Info.
Raphael Pharmaceutical is rated below average in return on asset category among its peers. It also is rated below average in shares outstanding category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Raphael Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Raphael Pharmaceutical's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Raphael Pharmaceutical Systematic Risk

Raphael Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Raphael Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Raphael Pharmaceutical correlated with the market. If Beta is less than 0 Raphael Pharmaceutical generally moves in the opposite direction as compared to the market. If Raphael Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Raphael Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Raphael Pharmaceutical is generally in the same direction as the market. If Beta > 1 Raphael Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.

Raphael Pharmaceutical December 4, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Raphael Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Raphael Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Raphael Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Raphael OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Raphael Pharmaceutical's daily price indicators and compare them against related drivers.

Complementary Tools for Raphael OTC Stock analysis

When running Raphael Pharmaceutical's price analysis, check to measure Raphael Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raphael Pharmaceutical is operating at the current time. Most of Raphael Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Raphael Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raphael Pharmaceutical's price. Additionally, you may evaluate how the addition of Raphael Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios